News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Accuses USV of Fudging Data



9/23/2013 7:20:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The United States Food and Drug Administration (USFDA) has accused Mumbai-based drugmaker USV of fudging data, adding to the list of domestic companies such as Ranbaxy Labs and WockhardtBSE -1.20 % that have come under the drug regulator's scanner. After an inspection of USV's Mumbai laboratory in June, the US drug regulator said the company's "drug product test method validation data is falsified", according to documents reviewed by ET. USV, one of India's top 20 drugmakers, is the third manufacturer after Mumbai-based Wockhardt and Hyderabad-based Posh Chemicals to be hauled up by the USFDA for allegedly tampering with data in the past three months.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES